Preparation by alkaline treatment and detailed characterisation of empty hepatitis B virus core particles for vaccine and gene therapy applications

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Strods, Arnis ^a   Ose, Velta ^a   Bogans, Janis ^a   Cielens, Indulis ^a   Kalnins, Gints ^a   Radovica, Ilze ^a   Kazaks, Andris ^a   Pumpens, Paul ^a   Renhofa, Regina ^a  

^a LATVIAN BIOMEDICAL RESEARCH AND STUDY CENTRE   (Latvia)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALI; HEPATITIS B CORE ANTIGEN; VIRUS LIKE PARTICLE VACCINE;

AMINO ACID SEQUENCE; CHEMISTRY; ELECTRON MICROSCOPY; GENE THERAPY; GENETICS; HEPATITIS B VIRUS; HYDROLYSIS; IMMUNOLOGY; METABOLISM; MOLECULAR GENETICS; MUTATION; PH; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROCEDURES; SEQUENCE HOMOLOGY; ULTRAVIOLET SPECTROPHOTOMETRY; VIRION; VIRUS ASSEMBLY;

ALKALIES; AMINO ACID SEQUENCE; ELECTROPHORESIS, POLYACRYLAMIDE GEL; GENETIC THERAPY; HEPATITIS B CORE ANTIGENS; HEPATITIS B VIRUS; HYDROGEN-ION CONCENTRATION; HYDROLYSIS; MICROSCOPY, ELECTRON; MOLECULAR SEQUENCE DATA; MUTATION; SEQUENCE HOMOLOGY, AMINO ACID; SPECTROPHOTOMETRY, ULTRAVIOLET; VACCINES, VIRUS-LIKE PARTICLE; VIRION; VIRUS ASSEMBLY;

EID: 84933556635     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep11639     Document Type: Article

References (75)

1. Kann, M. & Gerlich, W. H. Replication of hepatitis B virus in Molecular Medicine of Viral Hepatitis (eds T. J. Harrison & A. J. Zuckerman), 63-87 (John Wiley & Sons, 1997
2. Gerlich, W. H., Goldmann, U., Muller, R., Stibbe, W. & Wolff, W. Specificity and localization of the hepatitis B virus-Associated protein kinase. J Virol 42, 761-766 (1982
3. Zhou, S. & Standring, D. N. Hepatitis B virus capsid particles are assembled from core-protein dimer precursors. Proc Natl Acad Sci USA 89, 10046-10050 (1992
4. Cohen, B. J. & Richmond, J. E. Electron microscopy of hepatitis B core antigen synthesized in E. coli. Nature 296, 677-679 (1982
5. Packianathan, C., Katen, S. P., Dann, C. E., 3rd & Zlotnick, A. Conformational changes in the hepatitis B virus core protein are consistent with a role for allostery in virus assembly. J Virol 84, 1607-1615 doi: 10.1128/JVI.02033-09 (2010
6. Pumpens, P. & Grens, E. HBV core particles as a carrier for B cell/T cell epitopes. Intervirology 44, 98-114 doi: 50037 (2001
7. Crowther, R. A, et al. Three-dimensional structure of hepatitis B virus core particles determined by electron cryomicroscopy. Cell 77, 943-950 (1994
8. Roseman, A. M, et al. Structures of hepatitis B virus cores presenting a model epitope and their complexes with antibodies. J Mol Biol 423, 63-78 doi: 10.1016/j.jmb.2012.06.032 (2012
9. Wynne, S. A., Crowther, R. A. & Leslie, A. G. The crystal structure of the human hepatitis B virus capsid. Mol Cell 3, 771-780 (1999
10. Kniskern, P. J, et al. Unusually high-level expression of a foreign gene (hepatitis B virus core antigen) in Saccharomyces cerevisiae. Gene 46, 135-141 (1986
11. Miyanohara, A, et al. Expression of hepatitis B virus core antigen gene in Saccharomyces cerevisiae: synthesis of two polypeptides translated from different initiation codons. J Virol 59, 176-180 (1986
12. Rolland, D, et al. Purification of recombinant HBc antigen expressed in Escherichia coli and Pichia pastoris: comparison of sizeexclusion chromatography and ultracentrifugation. J Chromatogr B Biomed Sci Appl 753, 51-65 (2001
13. Freivalds, J, et al. Highly efficient production of phosphorylated hepatitis B core particles in yeast Pichia pastoris. Protein Expr Purif 75, 218-224 doi: 10.1016/j.pep.2010.09.010 (2011
14. Birnbaum, F. & Nassal, M. Hepatitis B virus nucleocapsid assembly: primary structure requirements in the core protein. J Virol 64, 3319-3330 (1990
15. Seifer, M. & Standring, D. N. A protease-sensitive hinge linking the two domains of the hepatitis B virus core protein is exposed on the viral capsid surface. J Virol 68, 5548-5555 (1994
16. Watts, N. R, et al. The morphogenic linker peptide of HBV capsid protein forms a mobile array on the interior surface. EMBO J 21, 876-884 doi: 10.1093/emboj/21.5.876 (2002
17. Chain, B. M. & Myers, R. Variability and conservation in hepatitis B virus core protein. BMC Microbiol 5, 33 doi: 10.1186/1471-2180-5-33 (2005
18. Pumpens, P, et al. Construction of novel vaccines on the basis of the virus-like particles: Hepatitis B virus proteins as vaccine carriers in Medicinal Protein Engineering (ed. Y. Khudyakov), 205-248 (CRC Press, Taylor & Francis Group, 2008
19. Whitacre, D. C., Lee, B. O. & Milich, D. R. Use of hepadnavirus core proteins as vaccine platforms. Expert Rev Vaccines 8, 1565-1573 doi: 10.1586/erv.09.121 (2009
20. Pushko, P., Pumpens, P. & Grens, E. Development of virus-like particle technology from small highly symmetric to large complex virus-like particle structures. Intervirology 56, 141-165 doi: 10.1159/000346773 (2013
21. Nassal, M. The arginine-rich domain of the hepatitis B virus core protein is required for pregenome encapsidation and productive viral positive-strand DNA synthesis but not for virus assembly. J Virol 66, 4107-4116 (1992
22. Hatton, T., Zhou, S. & Standring, D. N. RNA-And DNA-binding activities in hepatitis B virus capsid protein: a model for their roles in viral replication. J Virol 66, 5232-5241 (1992
23. Machida, A, et al. Antigenic sites on the arginine-rich carboxyl-Terminal domain of the capsid protein of hepatitis B virus distinct from hepatitis B core or e antigen. Mol Immunol 26, 413-421 (1989
24. Bundule, M. A, et al. [C-Terminal polyarginine tract of hepatitis B core antigen is located on the outer capsid surface]. Dokl Akad Nauk SSSR 312, 993-996 (1990
25. Vanlandschoot, P., Van Houtte, F., Serruys, B. & Leroux-Roels, G. The arginine-rich carboxy-Terminal domain of the hepatitis B virus core protein mediates attachment of nucleocapsids to cell-surface-expressed heparan sulfate. J Gen Virol 86, 75-84 doi: 10.1099/vir.0.80580-0 (2005
26. Meng, D., Hjelm, R. P., Hu, J. & Wu, J. A theoretical model for the dynamic structure of hepatitis B nucleocapsid. Biophys J 101, 2476-2484 doi: 10.1016/j.bpj.2011.10.002 (2011
27. Borisova, G. P, et al. Genetically engineered mutants of the core antigen of the human hepatitis B virus preserving the ability for native self-Assembly. Dokl Akad Nauk SSSR 298, 1474-1478 (1988
28. Gallina, A, et al. A recombinant hepatitis B core antigen polypeptide with the protamine-like domain deleted self-Assembles into capsid particles but fails to bind nucleic acids. J Virol 63, 4645-4652 (1989
29. Dhason, M. S., Wang, J. C., Hagan, M. F. & Zlotnick, A. Differential assembly of Hepatitis B Virus core protein on single-And double-stranded nucleic acid suggest the dsDNA-filled core is spring-loaded. Virology 430 20-29 doi: 10.1016/j.virol.2012.04.012 (2012
30. Shlomai, A., Lubelsky, Y., Har-Noy, O. & Shaul, Y. The "Trojan horse" model-delivery of anti-HBV small interfering RNAs by a recombinant HBV vector. Biochem Biophys Res Commun 390, 619-623 doi: 10.1016/j.bbrc.2009.10.016 (2009
31. Storni, T, et al. Nonmethylated CG motifs packaged into virus-like particles induce protective cytotoxic T cell responses in the absence of systemic side effects. J Immunol 172, 1777-1785 (2004
32. Kazaks, A., Balmaks, R., Voronkova, T., Ose, V. & Pumpens, P. Melanoma vaccine candidates from chimeric hepatitis B core virus-like particles carrying a tumor-Associated MAGE-3 epitope. Biotechnol J 3, 1429-1436 doi: 10.1002/biot.200800160 (2008
33. Cooper, A. & Shaul, Y. Recombinant viral capsids as an efficient vehicle of oligonucleotide delivery into cells. Biochem Biophys Res Commun 327, 1094-1099 doi: 10.1016/j.bbrc.2004.12.118 (2005
34. Newman, M., Chua, P. K., Tang, F. M., Su, P. Y. & Shih, C. Testing an electrostatic interaction hypothesis of hepatitis B virus capsid stability by using an in vitro capsid disassembly/reassembly system. J Virol 83, 10616-10626 doi: 10.1128/JVI.00749-09 (2009
35. Porterfield, J. Z, et al. Full-length hepatitis B virus core protein packages viral and heterologous RNA with similarly high levels of cooperativity. J Virol 84, 7174-7184 doi: 10.1128/JVI.00586-10 (2010
36. Renhofa, R., Dishlers, A., Ose-Klinklava, V., Ozols, J. & Pumpens, P., inventors. Latvian Biomedical Research and Study Centre, assignee. Packaging of magnetic nanoparticles into HBV core protein-formed capsids. Latvia patent. LV 14304 B. 20 May 2011
37. Renhofa, R, et al. inventors. Latvian Biomedical Research and Study Centre, assignee. Modificeti HBV core nanokonteineri ka universala platforma biologiska materiala eksponešanai. Latvia patent application. P-14-06. 13 Jan 2014
38. Renhofa, R, et al. inventors. Latvian Biomedical Research and Study Centre, assignee. Panemiens izveleta materiala piešušanai HBV core proteina veidotajam nanodalinam. Latvia patent application. P-14-05. 13 Jan 2014
39. Pushko, P, et al. Identification of hepatitis B virus core protein regions exposed or internalized at the surface of HBcAg particles by scanning with monoclonal antibodies. Virology 202, 912-920 doi: 10.1006/viro.1994.1413 (1994
40. Rabe, B, et al. Nuclear entry of hepatitis B virus capsids involves disintegration to protein dimers followed by nuclear reassociation to capsids. PLoS Pathog 5, e1000563 doi: 10.1371/journal.ppat.1000563 (2009
41. Machida, A, et al. Phosphorylation in the carboxyl-Terminal domain of the capsid protein of hepatitis B virus: evaluation with a monoclonal antibody. J Virol 65, 6024-6030 (1991
42. Lan, Y. T., Li, J., Liao, W. & Ou, J. Roles of the three major phosphorylation sites of hepatitis B virus core protein in viral replication. Virology 259, 342-348 doi: 10.1006/viro.1999.9798 (1999
43. Le Pogam, S., Chua, P. K., Newman, M. & Shih, C. Exposure of RNA templates and encapsidation of spliced viral RNA are influenced by the arginine-rich domain of human hepatitis B virus core antigen (HBcAg 165-173). J Virol 79, 1871-1887. doi: 10.1128/JVI.79.3.1871-1887.2005 (2005
44. Perlman, D. H., Berg, E. A., O'Connor, P. B., Costello, C. E. & Hu, J. Reverse transcription-Associated dephosphorylation of hepadnavirus nucleocapsids. Proc Natl Acad Sci USA 102, 9020-9025 doi: 10.1073/pnas.0502138102 (2005
45. Lewellyn, E. B. & Loeb, D. D. Serine phosphoacceptor sites within the core protein of hepatitis B virus contribute to genome replication pleiotropically. PLoS One 6, e17202 doi: 10.1371/journal.pone.0017202 (2011
46. Moses, S. E., Lim, Z. & Zuckerman, M. A. Hepatitis B virus infection: pathogenesis, reactivation and management in hematopoietic stem cell transplant recipients. Expert Rev Anti Infect Ther 9, 891-899 doi: 10.1586/eri.11.105 (2011
47. Schadler, S. & Hildt, E. HBV life cycle: entry and morphogenesis. Viruses 1, 185-209 doi: 10.3390/v1020185 (2009
48. Clarke, B. E, et al. Improved immunogenicity of a peptide epitope after fusion to hepatitis B core protein. Nature 330, 381-384. doi: 10.1038/330381a0 (1987
49. Borisova, G, et al. Recombinant capsid structures for exposure of protein antigenic epitopes. Mol Gen. (Life Sci Adv) 6, 169-174 (1987
50. Ranka, R, et al. Fibronectin-binding nanoparticles for intracellular targeting addressed by B. burgdorferi BBK32 protein fragments. Nanomedicine 9, 65-73 doi: 10.1016/j.nano.2012.05.003 (2013
51. Walker, A., Skamel, C. & Nassal, M. SplitCore: an exceptionally versatile viral nanoparticle for native whole protein display regardless of 3D structure. Sci Rep 1, 5 doi: 10.1038/srep00005 (2011
52. Lange, M, et al. Hepatitis C virus hypervariable region 1 variants presented on hepatitis B virus capsid-like particles induce cross-neutralizing antibodies. PLoS One 9, e102235 doi: 10.1371/journal.pone.0102235 (2014
53. Lee, K. W., Tey, B. T., Ho, K. L., Tejo, B. A. & Tan, W. S. Nanoglue: an alternative way to display cell-internalizing peptide at the spikes of hepatitis B virus core nanoparticles for cell-Targeting delivery. Mol Pharm 9, 2415-2423 doi: 10.1021/mp200389t (2012
54. Prasuhn, D. E., Jr, et al. Polyvalent display of heme on hepatitis B virus capsid protein through coordination to hexahistidine tags. Chem Biol 15, 513-519 doi: 10.1016/j.chembiol.2008.03.018 (2008
55. Gazina, E. V., Fielding, J. E., Lin, B. & Anderson, D. A. Core protein phosphorylation modulates pregenomic RNA encapsidation to different extents in human and duck hepatitis B viruses. J Virol 74, 4721-4728 (2000
56. Basagoudanavar, S. H., Perlman, D. H. & Hu, J. Regulation of hepadnavirus reverse transcription by dynamic nucleocapsid phosphorylation. J Virol 81, 1641-1649 doi: 10.1128/JVI.01671-06 (2007
57. Mabit, H. & Schaller, H. Intracellular hepadnavirus nucleocapsids are selected for secretion by envelope protein-independent membrane binding. J Virol 74, 11472-11478 (2000
58. Roseman, A. M., Berriman, J. A., Wynne, S. A., Butler, P. J. & Crowther, R. A. A structural model for maturation of the hepatitis B virus core. Proc Natl Acad Sci USA 102, 15821-15826 doi: 10.1073/pnas.0504874102 (2005
59. Zlotnick, A, et al. Localization of the C terminus of the assembly domain of hepatitis B virus capsid protein: implications for morphogenesis and organization of encapsidated RNA. Proc Natl Acad Sci USA 94, 9556-9561 (1997
60. Sominskaya, I, et al. A VLP library of C-Terminally truncated Hepatitis B core proteins: correlation of RNA encapsidation with a Th1/Th2 switch in the immune responses of mice. PLoS One 8, e75938 doi: 10.1371/journal.pone.0075938 (2013
61. Kann, M. & Gerlich, W. H. Effect of core protein phosphorylation by protein kinase C on encapsidation of RNA within core particles of hepatitis B virus. J Virol 68, 7993-8000 (1994
62. Beterams, G., Bottcher, B. & Nassal, M. Packaging of up to 240 subunits of a 17 kDa nuclease into the interior of recombinant hepatitis B virus capsids. FEBS Lett 481, 169-176 (2000
63. Song, S, et al. Augmented induction of CD8+ cytotoxic T-cell response and antitumor effect by DCs pulsed with virus-like particles packaging with CpG. Cancer Lett 256, 90-100 doi: 10.1016/j.canlet.2007.06.004 (2007
64. Song, S, et al. Significant anti-Tumour activity of adoptively transferred T cells elicited by intratumoral dendritic cell vaccine injection through enhancing the ratio of CD8(+ ) T cell/regulatory T cells in tumour. Clin Exp Immunol 162, 75-83. doi: 10.1111/j.1365-2249.2010.04226.x (2010
65. Braun, S, et al. Proteasomal degradation of core protein variants from chronic hepatitis B patients. J Med Virol 79, 1312-1321. doi: 10.1002/jmv.20939 (2007
66. Tumban, E., Peabody, J., Peabody, D. S. & Chackerian, B. A universal virus-like particle-based vaccine for human papillomavirus: longevity of protection and role of endogenous and exogenous adjuvants. Vaccine 31, 4647-4654 doi: 10.1016/j.vaccine.2013.07.052 (2013
67. Hastie, K. M., Kimberlin, C. R., Zandonatti, M. A., MacRae, I. J. & Saphire, E. O. Structure of the Lassa virus nucleoprotein reveals a dsRNA-specific 3 to 5 exonuclease activity essential for immune suppression. Proc Natl Acad Sci USA 108, 2396-2401. doi: 10.1073/pnas.1016404108 (2011
68. Jiang, X, et al. Structures of arenaviral nucleoproteins with triphosphate dsRNA reveal a unique mechanism of immune suppression. J Biol Chem 288, 16949-16959 doi: 10.1074/jbc.M112.420521 (2013
69. Guo, Y, et al. Crimean-Congo hemorrhagic fever virus nucleoprotein reveals endonuclease activity in bunyaviruses. Proc Natl Acad Sci USA 109, 5046-5051 doi: 10.1073/pnas.1200808109 (2012
70. Milich, D. R, et al. Role of B cells in antigen presentation of the hepatitis B core. Proc Natl Acad Sci USA 94, 14648-14653 (1997
71. Lazdina, U, et al. Molecular basis for the interaction of the hepatitis B virus core antigen with the surface immunoglobulin receptor on naive B cells. J Virol 75, 6367-6374 doi: 10.1128/JVI.75.14.6367-6374.2001 (2001
72. Cao, T, et al. Hepatitis B virus core antigen binds and activates naive human B cells in vivo: studies with a human PBL-NOD/.SCID mouse model. J Virol 75, 6359-6366 doi: 10.1128/JVI.75.14.6359-6366.2001 (2001
73. Ehresmann, B., Imbault, P. & Weil, J. H. Spectrophotometric determination of protein concentration in cell extracts containing tRNA's and rRNA's. Anal Biochem 54, 454-463 (1973
74. Lloyd, D. D. Delloyd's Lab Tech resources reagents and Solutions, http://delloyd.50megs.com/moreinfo/buffers2.html, (2014) (Date of access: 28/01/2015
75. Bichko, V., Pushko, P., Dreilina, D., Pumpen, P. & Gren, E. Subtype ayw variant of hepatitis B virus. DNA primary structure analysis. FEBS Lett 185, 208-212 (1985